Marksans Pharma - News
NSE: MARKSANS | BSE: 524404
₹329.70
As on 28-Aug-2026IST
Market cap
₹14,932 Cr
Revenue (TTM)
₹3,172 Cr
P/E Ratio
28.9
P/B Ratio
4.7
Div. Yield
0.3 %
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsResult For The Quarter Ended June 30 2026
12-Aug-2026No News & Announcements are available.